Wealthspire Advisors (New York)’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,750
Closed -$61K 537
2021
Q3
$61K Buy
+11,750
New +$61K ﹤0.01% 572